The zinc finger domains in U2AF26 and U2AF35 have diverse functionalities including a role in controlling translation

References

• Wahl MC, Will CL, Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell. 2009;136:701–718.
   PubMed Web of Science ®Google Scholar
• Zamore PD, Patton JG, Green MR. Cloning and domain structure of the mammalian splicing factor U2AF. Nature. 1992;355:609–614.
   PubMed Web of Science ®Google Scholar
• Zorio DA, Blumenthal T. Both subunits of U2AF recognize the 3ʹ splice site in Caenorhabditis elegans. Nature. 1999;402:835–838.
   PubMed Web of Science ®Google Scholar
• Merendino L, Guth S, Bilbao D, et al. Inhibition of msl-2 splicing by sex-lethal reveals interaction between U2AF35 and the 3ʹ splice site AG. Nature. 1999;402:838–841.
   PubMed Web of Science ®Google Scholar
• Wu S, Romfo CM, Nilsen TW, et al. Functional recognition of the 3ʹ splice site AG by the splicing factor U2AF35. Nature. 1999;402:832–835.
   PubMed Web of Science ®Google Scholar
• Mackereth CD, Madl T, Bonnal S, et al. Multi-domain conformational selection underlies pre-mRNA splicing regulation by U2AF. Nature. 2011;475:408–411.
   PubMed Web of Science ®Google Scholar
• Kielkopf CL, Rodionova NA, Green MR, et al. A novel peptide recognition mode revealed by the X-ray structure of a core U2AF35/U2AF65 heterodimer. Cell. 2001;106:595–605.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Park S-Y, Oda T, et al. A novel 3ʹ splice site recognition by the two zinc fingers in the U2AF small subunit. Genes Dev. 2015;29:1649–1660.
   PubMed Web of Science ®Google Scholar
• Kralovicova J, Vorechovsky I. Alternative splicing of U2AF1 reveals a shared repression mechanism for duplicated exons. Nucleic Acids Res. 2017;45:417–434.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zamore PD, Carmo-Fonseca M, et al. Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunit. Proc Natl Acad Sci U S A. 1992;89:8769–8773.
   PubMed Web of Science ®Google Scholar
• Webb CJ, Wise JA. The splicing factor U2AF small subunit is functionally conserved between fission yeast and humans. Mol Cell Biol. 2004;24:4229–4240.
   PubMed Web of Science ®Google Scholar
• Wu T, Fu XD. Genomic functions of U2AF in constitutive and regulated splicing. RNA Biol. 2015;12:479–485.
   PubMed Web of Science ®Google Scholar
• Gama-Carvalho M, Carvalho MP, Kehlenbach A, et al. Nucleocytoplasmic shuttling of heterodimeric splicing factor U2AF. J Biol Chem. 2001;276:13104–13112.
   PubMed Web of Science ®Google Scholar
• Kielkopf CL, Lucke S, Green MR. U2AF homology motifs: protein recognition in the RRM world. Genes Dev. 2004;18:1513–1526.
   PubMed Web of Science ®Google Scholar
• Mollet I, Barbosa-Morais NL, Andrade J, et al. Diversity of human U2AF splicing factors. Febs J. 2006;273:4807–4816.
   PubMed Web of Science ®Google Scholar
• Shepard J, Reick M, Olson S, et al. Characterization of U2AF26, a splicing factor related to U2AF35. Mol Cell Biol. 2002;22:221–230.
   PubMed Web of Science ®Google Scholar
• Heyd F, Ten Dam G, Moroy T. Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooperate directly in regulating CD45 alternative splicing. Nat Immunol. 2006;7:859–867.
   PubMed Web of Science ®Google Scholar
• Heyd F, Carmo-Fonseca M, Moroy T. Differential isoform expression and interaction with the P32 regulatory protein controls the subcellular localization of the splicing factor U2AF26. J Biol Chem. 2008;283:19636–19645.
   PubMed Web of Science ®Google Scholar
• Preussner M, Wilhelmi I, Schultz A-S, et al. Rhythmic U2af26 alternative splicing controls PERIOD1 stability and the circadian clock in mice. Mol Cell. 2014;54:651–662.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64–69.
   PubMed Web of Science ®Google Scholar
• Graubert TA, Shen D, Ding L, et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet. 2011;44:53–57.
   PubMed Web of Science ®Google Scholar
• Makishima H, Visconte V, Sakaguchi H, et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood. 2012;119:3203–3210.
   PubMed Web of Science ®Google Scholar
• Przychodzen B, Jerez A, Guinta K, et al. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Blood. 2013;122:999–1006.
   PubMed Web of Science ®Google Scholar
• Ilagan JO, Ramakrishnan A, Hayes B, et al. U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Res. 2015;25:14–26.
   PubMed Web of Science ®Google Scholar
• Okeyo-Owuor T, White BS, Chatrikhi R, et al. U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing. Leukemia. 2015;29:909–917.
   PubMed Web of Science ®Google Scholar
• Shirai CL, Ley J, White B, et al. Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo. Cancer Cell. 2015;27:631–643.
   PubMed Web of Science ®Google Scholar
• Herdt O, Neumann A, Timmermann B, et al. The cancer-associated U2AF35 470A>G (Q157R) mutation creates an in-frame alternative 5ʹ splice site that impacts splicing regulation in Q157R patients. RNA. 2017;23:1796–1806.
   PubMed Web of Science ®Google Scholar
• Palangat M, Anastasakis DG, Fei DL, et al. The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation. Genes Dev. 2019;33:482–497.
   PubMed Web of Science ®Google Scholar
• Kellenberger E, Stier G, Sattler M. Induced folding of the U2AF35 RRM upon binding to U2AF65. FEBS Lett. 2002;528:171–176.
   PubMed Web of Science ®Google Scholar
• Shao C, Yang B, Wu T, et al. Mechanisms for U2AF to define 3ʹ splice sites and regulate alternative splicing in the human genome. Nat Struct Mol Biol. 2014;21:997–1005.
   PubMed Web of Science ®Google Scholar
• Shepard JB. Characterization of U2AF26, a paralog of the splicing factor U2AF35 [Dissertation]. Univ. Texas Southwest. Med. Cent; 2004.
   Google Scholar
• Preussner M, Goldammer G, Neumann A, et al. Body temperature cycles control rhythmic alternative splicing in mammals. Mol Cell. 2017;67:433–446.e434.
   PubMed Web of Science ®Google Scholar
• Lin X, Miller JW, Mankodi A, et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet. 2006;15:2087–2097.
   PubMed Web of Science ®Google Scholar
• Terenzi F, Ladd AN. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity. RNA Biol. 2010;7:43–55.
   PubMed Web of Science ®Google Scholar
• Poulos MG, Batra R, Li M, et al. Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice. Hum Mol Genet. 2013;22:3547–3558.
   PubMed Web of Science ®Google Scholar
• Kotta-Loizou I, Giaginis C, Theocharis S. Clinical significance of HuR expression in human malignancy. Med Oncol. 2014;31:161.
   PubMed Web of Science ®Google Scholar
• Fagg WS, Liu N, Fair JH, et al. Autogenous cross-regulation of Quaking mRNA processing and translation balances Quaking functions in splicing and translation. Genes Dev. 2017;31:1894–1909.
   PubMed Web of Science ®Google Scholar
• Michel SL, Guerrerio AL, Berg JM. Selective RNA binding by a single CCCH zinc-binding domain from Nup475 (Tristetraprolin). Biochemistry. 2003;42:4626–4630.
   PubMed Web of Science ®Google Scholar
• Twyffels L, Gueydan C, Kruys V. Shuttling SR proteins: more than splicing factors. Febs J. 2011;278:3246–3255.
   PubMed Web of Science ®Google Scholar
• Lemaire R, Prasad J, Kashima T, et al. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins. Genes Dev. 2002;16:594–607.
   PubMed Web of Science ®Google Scholar
• Sanford JR, Ellis JD, Cazalla D, et al. Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/alternative splicing factor. Proc Natl Acad Sci U S A. 2005;102:15042–15047.
   PubMed Web of Science ®Google Scholar
• Martinez NM, Pan Q, Cole BS, et al. Alternative splicing networks regulated by signaling in human T cells. RNA. 2012;18:1029–1040.
   PubMed Web of Science ®Google Scholar
• Schultz AS, Preussner M, Bunse M, et al. Activation-dependent TRAF3 exon 8 alternative splicing is controlled by CELF2 and hnRNP C binding to an upstream intronic element. Mol Cell Biol. 2017;37. DOI:10.1128/mcb.00488-16.
   PubMed Web of Science ®Google Scholar
• Liebmann M, Hucke S, Koch K, et al. Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity. Proc Natl Acad Sci U S A. 2018;115:E8017–e8026.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang Y, Lu H, et al. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction. Nature. 2019. DOI:10.1038/s41586-019-0979-8.
   Google Scholar
• Chen J, López-Moyado IF, Seo H, et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature. 2019. DOI:10.1038/s41586-019-0985-x.
   Web of Science ®Google Scholar
• Wilhelmi I, Kanski R, Neumann A, et al. Sec16 alternative splicing dynamically controls COPII transport efficiency. Nat Commun. 2016;7:12347.
   PubMed Web of Science ®Google Scholar
• Buchan DW, Minneci F, Nugent TC, et al. Scalable web services for the PSIPRED protein analysis workbench. Nucleic Acids Res. 2013;41:W349–357.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012;29:15–21. DOI: 10.1093/bioinformatics/bts635%J Bioinformatics.
   PubMed Web of Science ®Google Scholar
• DeLuca DS, Levin JZ, Sivachenko A, et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics. 2012;28:1530–1532.
   PubMed Web of Science ®Google Scholar